Goldman Sachs Group Inc Anika Therapeutics, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIK
# of Institutions
118Shares Held
11.8MCall Options Held
2.7KPut Options Held
5K-
Trigran Investments, Inc.2.14MShares$36.6 Million5.66% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$27.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA790KShares$13.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX749KShares$12.8 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny598KShares$10.2 Million0.03% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $250M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...